BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26227398)

  • 21. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-γ (PPARγ) and AMP-activated protein kinase (AMPK) pathways.
    Huang B; Yuan HD; Kim DY; Quan HY; Chung SH
    J Agric Food Chem; 2011 Apr; 59(8):3666-73. PubMed ID: 21401097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    Endocrinology; 2009 Feb; 150(2):862-70. PubMed ID: 19147680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
    Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
    Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responses.
    Brown JD; Oligino E; Rader DJ; Saghatelian A; Plutzky J
    PLoS One; 2011; 6(7):e21209. PubMed ID: 21750705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
    Takamura T; Nohara E; Nagai Y; Kobayashi K
    Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The DLK gene is a transcriptional target of PPARγ.
    Couture JP; Blouin R
    Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes.
    Ahmed RA; Murao K; Imachi H; Yu X; Li J; Wong NC; Ishida T
    Endocrine; 2009 Apr; 35(2):233-42. PubMed ID: 19156545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PPARs Mediate the Regulation of Energy Metabolism By Long-Chain Fatty Acids].
    Yan Y; Wang ZB; Tang CK
    Sheng Li Ke Xue Jin Zhan; 2016 Feb; 47(1):1-6. PubMed ID: 27424398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinnamaldehyde Ameliorates Diet-Induced Obesity in Mice by Inducing Browning of White Adipose Tissue.
    Zuo J; Zhao D; Yu N; Fang X; Mu Q; Ma Y; Mo F; Wu R; Ma R; Wang L; Zhu R; Liu H; Zhang D; Gao S
    Cell Physiol Biochem; 2017; 42(4):1514-1525. PubMed ID: 28719892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
    Hummasti S; Tontonoz P
    Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals.
    Codner E; Loviscach M; Ciaraldi TP; Rehman N; Carter L; Mudaliar S; Henry RR
    Metabolism; 2001 Jul; 50(7):830-4. PubMed ID: 11436190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
    Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
    Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cow's milk increases the activities of human nuclear receptors peroxisome proliferator-activated receptors alpha and delta and retinoid X receptor alpha involved in the regulation of energy homeostasis, obesity, and inflammation.
    Suhara W; Koide H; Okuzawa T; Hayashi D; Hashimoto T; Kojo H
    J Dairy Sci; 2009 Sep; 92(9):4180-7. PubMed ID: 19700678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.
    Luquet S; Gaudel C; Holst D; Lopez-Soriano J; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochim Biophys Acta; 2005 May; 1740(2):313-7. PubMed ID: 15949697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.
    Steinmetz M; Quentin T; Poppe A; Paul T; Jux C
    Basic Res Cardiol; 2005 May; 100(3):263-9. PubMed ID: 15754086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
    He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
    Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes.
    Jörgensen JA; Zadravec D; Jacobsson A
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1159-68. PubMed ID: 17726147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.